Human induced pluripotent stem cells (iPSCs) have emerged as an alternative source of
pluripotent stem cells that can be used for tissue regeneration in place of the controversial …

Human induced pluripotent stem cells (iPSCs) are a potential source of blood cells for
transfusion therapies and a promising tool for studying the ontogeny of hematopoiesis. The …

Human embryonic stem cells (hESCs), initially thought to be immune privileged cells, are
now known to be susceptible to immune recognition. Human induced pluripotent stem cells …

Advances in human stem cell technologies enable induced pluripotent stem cells (iPSCs) to
be explored as potent candidates for treating various diseases, such as malignancies …

Recently, induced pluripotent stem cells (iPSCs) were established as promising cell sources
for revolutionary regenerative therapies. The initial culture system used for iPSC generation …

The breakthrough of induced pluripotent stem cell (iPSC) technology has raised the
possibility that patient-specific iPSCs may become a renewable source of autologous cells …

The prospects for using autologous induced pluripotent stem cells (iPSCs) in cell
replacement therapy have been tempered by evidence that undifferentiated, syngeneic …

Lymphohematopoietic stem cells (L-HSCs) generated from self-somatic cell-derived induced
pluripotent stem cells (iPSCs) are a potential source of cells for the treatment of …

Lineage-restricted cells can be reprogrammed to a pluripotent state known as induced
pluripotent stem (iPS) cells through overexpression of 4 transcription factors. iPS cells are …

The ever-improving technology to generate induced pluripotent stem cells (iPSCs) has
increased their potential use as novel candidates for disease modeling, drug screening …